Callyope is an unclaimed profile.
If you work at Callyope, sign up or log in to claim the profile today.
Callyope
Callyope
Callyope is an AI-driven mental health monitoring platform that analyzes speech patterns to assess psychiatric conditions such as depression, bipolar disorder, and cognitive deficits. Patients complete a one-minute voice test via smartphone, either at home or in a clinical setting, and the system evaluates speech features like vocabulary, speech rate, and prosody to predict clinical scores.
Product Overview
Callyope is an AI-driven mental health monitoring platform that analyzes speech patterns to assess psychiatric conditions such as depression, bipolar disorder, and cognitive deficits. Patients complete a one-minute voice test via smartphone, either at home or in a clinical setting, and the system evaluates speech features like vocabulary, speech rate, and prosody to predict clinical scores. This technology enables psychiatrists to remotely monitor patients, personalize treatments, and potentially reduce hospital readmissions. Callyope's approach does not require a speech baseline, making it adaptable for new users.
Customers Served
Categories
Company Info
HQ Location
Not available
Founded
Not available
Headcount
Not available
Total Funding
Not available
Latest Round
Not available
Latest Round
Not available
Company Socials
Digital Diagnostics
Digital Diagnostics LumineticsCore
Company Info
Founded: 2010
Headcount: 51-200
Customers
Verified Customers: 3
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: HIPAA
LumineticsCore by Digital Diagnostics is an AI diagnostic system that autonomously detects diabetic retinopathy, including macular edema, at the point-of-care using fundus images captured by a trained operator. It provides rapid results without needing specialist review, which facilitates immediate care decisions and referrals if disease is detected. The system is designed for healthcare providers, eye care professionals, payors, and patients, enhancing access to diagnostic evaluations for people with diabetes.
Other Categories
Kintsugi
Kintsugi
Company Info
Founded: 2019
Headcount: 11-50
Customers
Customers Served: Ambulatory Practice, Hospital / Health System
Product Overview
Security and Compliance Certifications: SOC 2 Type 2, HIPAA, GDPR
Kintsugi develops AI-driven voice biomarker technology to detect signs of depression and anxiety from brief, free-form speech samples. Their primary offering, Kintsugi Voice, is an API-first platform that integrates with call centers, telehealth systems, and remote patient monitoring applications to identify mental health challenges in real time. This technology analyzes vocal features without relying on the content of speech, enabling language-agnostic assessments.
Other Categories
Paige
Paige
Company Info
Founded: 2018
Headcount: 51-200
Customers
Verified Customers: 9
Customers Served: Hospital / Health System, Ambulatory Practice, Life Sciences
Product Overview
Security and Compliance Certifications: ISO 13485, FDA Approval
Paige offers an AI-powered digital pathology platform designed to assist pathologists in diagnosing cancer and other diseases from pathology slides. The platform includes tools for detecting, quantifying, and visualizing tumor areas, providing decision support and streamlining workflows. Paige's AI models are trained on large datasets of pathology images and integrate with existing lab systems to enhance diagnostic accuracy and efficiency in clinical settings.
Other Categories